Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) may trigger severe pneumonia in coronavirus disease of 2019 (COVID-19) patients through release of damage-associated molecular patterns (DAMPs) and recruitment of neutrophils in the lungs. Activated neutrophils induce inflammat...

Descripción completa

Detalles Bibliográficos
Autores principales: Desilles, J. P., Gregoire, C., Le Cossec, C., Lambert, J., Mophawe, O., Losser, M. R., Lambiotte, F., Le Tacon, S., Cantier, M., Engrand, N., Trouiller, P., Pottecher, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303591/
https://www.ncbi.nlm.nih.gov/pubmed/32560746
http://dx.doi.org/10.1186/s13063-020-04488-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303591/
https://www.ncbi.nlm.nih.gov/pubmed/32560746
http://dx.doi.org/10.1186/s13063-020-04488-8

Ejemplares similares